IN161391B - - Google Patents

Info

Publication number
IN161391B
IN161391B IN1382/CAL/83A IN1382CA1983A IN161391B IN 161391 B IN161391 B IN 161391B IN 1382CA1983 A IN1382CA1983 A IN 1382CA1983A IN 161391 B IN161391 B IN 161391B
Authority
IN
India
Application number
IN1382/CAL/83A
Other languages
English (en)
Inventor
Richard Mark Stern
Original Assignee
Riker Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riker Laboratories Inc filed Critical Riker Laboratories Inc
Publication of IN161391B publication Critical patent/IN161391B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D455/00Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Quinoline Compounds (AREA)
IN1382/CAL/83A 1982-11-12 1983-11-11 IN161391B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/441,245 US4472405A (en) 1982-11-12 1982-11-12 Antimicrobial 6,7-dihydro-5,8-dimethyl-9 fluoro-1-oxo-1H, 5H-benzo (ij) quinolizine-2-carboxylic acid and derivatives

Publications (1)

Publication Number Publication Date
IN161391B true IN161391B (pt) 1987-11-28

Family

ID=23752110

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1382/CAL/83A IN161391B (pt) 1982-11-12 1983-11-11

Country Status (22)

Country Link
US (1) US4472405A (pt)
EP (1) EP0109284B1 (pt)
JP (1) JPH0826017B2 (pt)
KR (1) KR890000864B1 (pt)
AT (1) ATE39926T1 (pt)
AU (1) AU568319B2 (pt)
CA (2) CA1254568A (pt)
CS (1) CS390391A3 (pt)
DE (1) DE3378912D1 (pt)
EG (1) EG16492A (pt)
ES (1) ES527163A0 (pt)
FI (1) FI73213C (pt)
GR (1) GR79402B (pt)
IE (1) IE56232B1 (pt)
IL (1) IL70198A (pt)
IN (1) IN161391B (pt)
MX (1) MX7314E (pt)
NO (1) NO160782C (pt)
NZ (1) NZ206233A (pt)
OA (1) OA07586A (pt)
PT (1) PT77649B (pt)
ZA (1) ZA838436B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3519926A1 (de) * 1985-06-04 1986-12-04 Bayer Ag Indolinderivate, verfahren zu ihrer herstellung und diese indolinderivate enthaltende kosmetische lichtschutzmittel
CA1302413C (en) * 1986-01-22 1992-06-02 Bruce E. Williams Process for 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo- 1h,5h-benzo[ij]quinolizine-2-carboxylic acid
US4898945A (en) * 1986-01-22 1990-02-06 Minnesota Mining And Manufacturing Company Process for 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo-1H,5H-benzo[i,j]quinolizine-2-carboxylic acid
GB9827865D0 (en) * 1998-12-18 1999-02-10 Woodcock Fiona Medicament
DE10312346A1 (de) * 2003-03-20 2004-09-30 Bayer Healthcare Ag Kontrolliertes Freisetzungssystem
DE10351448A1 (de) 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
DE102006010643A1 (de) 2006-03-08 2007-09-13 Bayer Healthcare Aktiengesellschaft Arzneimittel enthaltend Fluorchinolone
DE102006010642A1 (de) * 2006-03-08 2007-09-27 Bayer Healthcare Aktiengesellschaft Arzneimittelformulierungen, enthaltend Fluorchinolone
DE102007026550A1 (de) * 2007-06-08 2008-12-11 Bayer Healthcare Ag Extrudate mit verbesserter Geschmacksmaskierung
DE102007055341A1 (de) 2007-11-19 2009-05-20 Bayer Animal Health Gmbh Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren
CA2814082A1 (en) 2010-10-12 2012-04-19 Bayer Intellectual Property Gmbh Non-starch based soft chewables
CA2895254C (en) 2012-12-19 2021-01-26 Bayer Animal Health Gmbh Tablets with improved acceptance and good storage stability
MD4291C1 (ro) * 2013-12-27 2015-02-28 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Preparat medicamentos pentru tratamentul otitelor
US20210068425A1 (en) * 2019-09-06 2021-03-11 Bayer Healthcare Llc Palatable granular veterinary compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE793524A (fr) * 1971-12-30 1973-06-29 Riker Laboratories Inc Acides benzoquinolizine-carboxyliques et leurs derives
ZA728444B (en) * 1971-12-30 1973-10-31 Riker Laboratories Inc Substituted benzo(ij)quinolizine-2-carboxylic acids and derivatives thereof
JPS5630964A (en) * 1979-08-22 1981-03-28 Kyorin Pharmaceut Co Ltd Novel substituted quinolinecarboxylic acid and its preparation
JPS5655388A (en) 1979-10-11 1981-05-15 Otsuka Pharmaceut Co Ltd Benzo ij quinolidine-2-carboxylic acid derivative, and its preparation
US4301289A (en) * 1980-02-19 1981-11-17 Minnesota Mining And Manufacturing Company Process for 6,7-dihydro-9-fluoro-5-methyl-1-oxo-1H,5H-benzo(ij)quinolizine-2-carboxylic acid
JPS59155381A (ja) * 1983-02-22 1984-09-04 Kyorin Pharmaceut Co Ltd ベンゾキノリジンカルボン酸誘導体及びその製造法

Also Published As

Publication number Publication date
FI834147A0 (fi) 1983-11-11
DE3378912D1 (de) 1989-02-16
FI73213C (fi) 1987-09-10
FI834147A (fi) 1984-05-13
IE56232B1 (en) 1991-05-22
CA1254568A (en) 1989-05-23
CA1280755C (en) 1991-02-26
ATE39926T1 (de) 1989-01-15
NO160782B (no) 1989-02-20
EP0109284B1 (en) 1989-01-11
GR79402B (pt) 1984-10-22
OA07586A (fr) 1985-03-31
PT77649B (en) 1986-03-19
EP0109284A1 (en) 1984-05-23
ES8504727A1 (es) 1985-05-01
IL70198A (en) 1988-11-15
EG16492A (en) 1994-11-30
FI73213B (fi) 1987-05-29
AU568319B2 (en) 1987-12-24
KR840006659A (ko) 1984-12-01
IE832639L (en) 1984-05-12
KR890000864B1 (ko) 1989-04-11
NO160782C (no) 1989-05-31
PT77649A (en) 1983-12-01
JPS59112969A (ja) 1984-06-29
ZA838436B (en) 1985-06-26
JPH0826017B2 (ja) 1996-03-13
ES527163A0 (es) 1985-05-01
AU2118183A (en) 1984-05-17
NZ206233A (en) 1986-10-08
US4472405A (en) 1984-09-18
CS390391A3 (en) 1992-09-16
IL70198A0 (en) 1984-02-29
NO834093L (no) 1984-05-14
MX7314E (es) 1988-05-11

Similar Documents

Publication Publication Date Title
FR2524826B1 (pt)
FR2520946B1 (pt)
DE3232093C2 (pt)
JPS611432B2 (pt)
DE3310545C2 (pt)
FR2522552B1 (pt)
FR2520762B1 (pt)
FR2520430B1 (pt)
FR2521445B3 (pt)
DE3212649C2 (pt)
FR2519771B1 (pt)
DE3318953C2 (pt)
FR2521065B1 (pt)
FR2520115B1 (pt)
FR2520333B1 (pt)
FR2520809B1 (pt)
FR2520168B1 (pt)
DE3246437C2 (pt)
FR2520716B1 (pt)
FR2520588B3 (pt)
DE3234171C2 (pt)
FR2521649B1 (pt)
FR2520995B3 (pt)
FR2520673B3 (pt)
FR2519891B1 (pt)